Advanced Biomaterials for Nerve Regeneration
Our mission
We are dedicated to developing innovative technologies for nerve repair and regeneration
our target
Peripheral nerve injuries are common results of trauma, cancer, and chronic disease, leading to $20B in annual US health care costs
our solution
We have developed biodegradable drug-delivery implants to regenerate injured nerves
Swan NeuroTech is developing a portfolio of biomaterial-based drug delivery technologies
nerve graft conduits
Tunable polymer chemistry for improved mechanical properties
controlled drug delivery
Polymer microsphere technology for optimized drug release kinetics
manufacturing
innovation
Additive manufacturing using proprietary polymer dipping technology
biodegradable materials
Long duration implants with safe degradation products
Meet our Team
Get to know our Management Team and Advisors
Kacey Marra, PhD
Founder & Chief Scientific Officer
Kacey is an scientific innovator in regenerative medicine, drug-delivery, and polymer science. She is a tenured Professor in the Departments of Plastic Surgery and Bioengineering at the University of Pittsburgh.
Jeremy Kimmel, PhD
Chief Executive Officer
Jeremy is an experienced leader in business strategy, product development, and commercialization. He has helped launch numerous implantable medical products in the United States and Europe.
Anthony Windebank, MD
Clinical Advisor
Kia Washington, MD
Clinical Advisor
Steve Winowich
Business Advisor
Arta Kelmendi-Doko, MD, PhD
Scientific Advisor
Pamela Vidmar, MBA
Business Advisor
Rachel Allen-Lorey
Corporate Counsel, Business Advisor
Contact Info
Let’s Chat
Get in touch with us to learn more!
